Taysha Gene Therapies, Inc.

Siren, L.L.C. TSHA
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/13/2026
Shares
10,129,913
Value ($000)
55,715
Weight
1.7%
2024 Q3 - 2025 Q4 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).